Peripheral blood mononuclear cell proliferative responses in uitro to recombinant yeast or Escherichia coli hepatitis C virus fusion proteins were evaluated in 20 patients with chronic hepatitis C who were reactive for antibody to hepatitis C virus (on enzyme immunoassay, version 2.0, and a four-ant
Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus
✍ Scribed by Maria-Christina Jung; Marietta Stemler; Thomas Weimer; Ulrich Spengler; Jutta Döhrmann; Robert Hoffmann; Dieter Eichenlaub; Josef Eisenburg; Gustav Paumgartner; Gert Riethmüller; Hans Will; Gerd R. Pape
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 732 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg. We have investigated whether this antigen is a target structure for human T-lymphocytes. Using recombinant HBxAg protein, we found HBxAg-specific stimulation of peripheral blood mononuclear cells in patients with acute hepatitis B virus infection (6 of 6) and chronic hepatitis B virus infection (6 of 17) but not in healthy individuals. With HBxAg-specific synthetic polypeptides, several T-cell epitopes were identified. Most were located in the carboxyterminal half of the HBxAg protein. Five T-cell clones specific for a T-cell epitope located at the carboxyterminal region of HBxAg were established and found to belong to the CD2/CD4-positive, CDS-negative subtype. These data establish for the first time HBxAg as an antigen in the cellular immune response. (HEPATOLOGY 1991;13:637-643.)
Human HBV infection still represents one of the major world health problems and its sequelae range from inapparent infection and acute and chronic hepatitis to hepatic cirrhosis and the development of liver cancer (1). Some of the pathogenic features, including the development of liver cell carcinoma, are also seen in the infection of animals with related viruses (2). HBVs, which belong to the hepadnavirus family, are not cytopathogenic, and therefore immune response mechanisms of the infected host are believed to determine the outcome of infection (3, 4).
Thus far, the roles of viral structural proteins and derivatives thereof have been analyzed as antigens for B-cell and T-cell responses. The humoral and cellular immune response to HBsAg, pre-S1Ag and pre-S2Ag and to HBcAg and HBeAg has been investigated in some detail (5)(6)(7)(8)(9)(10)(11). For two known nonstructural proteins,
📜 SIMILAR VOLUMES
## Abstract The integration of hepatitis B virus (HBV) DNA in the liver of chronic HBV carriers has been documented extensively. However, the status of the viral genome during acute infection has not been assessed conclusively. While HBV DNA sequences are detected often in serum, liver, and periphe
## Abstract The presence of both hepatitis B virus (HBV) DNA and HBV antigens (HBsAg, HBeAg) was assessed in peripheral blood mononuclear cells (PBMC) from 32 patients chronically infected with HBV. Three different molecular forms of HBV DNA were observed: free monomers (5), high‐molecular‐weight f
## Abstract The polymerase chain reaction (PCR) was used to investigate the presence of positive and negative hepatitis C virus (HCV) RNA strands in serumand peripheral blood mononuclear cells (PBMC) of 20 patients with histologically proven HCV‐ related chronic liver disease. All patients complete
## Abstract Hepatitis B virus (HBV) infection of peripheral blood mononuclear cells (PBMCs) has been observed in all stages of liver disease. Thus far all information about the physical state of HBV in mononuclear blood cells comes from Southern blot analysis and in situ hybridization. In this stud
## VICENTE CARRENO The presence of hepatitis B virus DNA was studied in peripheral blood mononuclear cell samples from 259 HBsAg carriers (229 anti-hepatitis delta negative, 30 anti-hepatitis delta positive), 16 anti-HBc-positive HBsAg-negative patients and 30 patients without hepatitis B virus ma